Last reviewed · How we verify
SF Easyhaler
At a glance
| Generic name | SF Easyhaler |
|---|---|
| Sponsor | Orion Corporation, Orion Pharma |
| Modality | Small molecule |
| Phase | Phase 1 |
Approved indications
Common side effects
Key clinical trials
- Comparison of Salmeterol and Fluticasone Propionate Absorption From Salmeterol/Fluticasone Easyhaler With Seretide Diskus (PHASE1)
- Comparison of Salmeterol and Fluticasone Propionate Absorption From Salmeterol/Fluticasone Easyhaler and Seretide Diskus (PHASE1)
- Inspiratory Flow Parameters of Easyhaler and Diskus Inhalers (SALIF) (NA)
Primary sources
Every claim on this page is sourced from regulatory or scientific primary sources. See our editorial policy for full methodology.
| Source | Used for |
|---|---|
| ClinicalTrials.gov | Trial enrolment, design, endpoints, results |
Competitive intelligence
For the full competitive landscape — auto-detected comparators, recent regulatory actions across the set, upcoming PDUFA, patent timeline, sponsor landscape:
- SF Easyhaler CI brief — competitive landscape report
- SF Easyhaler updates RSS · CI watch RSS
- Orion Corporation, Orion Pharma portfolio CI